Question 1:

What are Good Pharmacovigilance Process and Good Post-Marketing Surveillance Process? How do they differ from each other?

Define and illustrate briefly Good Post-Marketing Surveillance Process (GPMSP)
Define and illustrate briefly Good Pharmacovigilance Process (GPVP)
Differentiate between Good Pharmacovigilance Process and Post-Marketing Surveillance Process

Question 2:

a) Regulatory authorities should improve efforts to compute the effectiveness of the various reporting mechanisms in operation in their countries.

b) Good pharmacoepidemiological practice facilitates the appropriate utilization of technical resources by promoting careful study design and planning of study conduct.

Show regulatory improvement happing in different countries to evaluate the effectiveness of the various reporting mechanisms

Show the significance or role of Good pharmacoepidemiological practice in promoting careful study design and planning of study conduct